Affiliation:
1. Dermatology Oakland California USA
2. University of Kansas Cancer Center and the University of Kansas Medical Center Kansas City Kansas USA
Abstract
AbstractPatients with cutaneous T‐cell lymphoma with progressive disease typically undergo a series of skin‐directed and systemic therapy regimens during cycles of response and relapse. Extracorporeal photopheresis (ECP) is an effective and safe systemic treatment option, often reserved for later stages of disease and typically employed after failure of several other therapies. ECP has benefits in response rate, time to next treatment, and tolerability that may support its use earlier in the treatment cycle for advancing/progressing disease.
Funder
Mallinckrodt Pharmaceuticals
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference66 articles.
1. Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients
2. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Primary Cutaneous Lymphomas.©National Comprehensive Cancer Center Network Inc. 2023. All rights reserved. To View the Most Recent and Complete Version of the Guideline Go Online to NCCN.Org. NCCN Makes No Warranties of Any Kind Whatsoever Regarding Their Content Use or Application and Disclaims Any Responsibility for Their Application or Use in Any WayV.1.2023.NCCN National Comprehensive Cancer Network®(NCCN®);2023.
3. Update on Biology of Cutaneous T-Cell Lymphoma
4. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
5. Systemic therapy of cutaneous T-cell lymphoma (CTCL)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献